XML 86 R72.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation - Share Based Payment Award Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Mar. 31, 2018
Apr. 01, 2017
Apr. 02, 2016
Mar. 28, 2015
Performance Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 593,265 643,565 400,987 593,704
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 8.76 $ 6.85 $ 6.93 $ 7.88
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 222,400 643,565 0  
Grant date fair value per share $ 12.17 $ 6.85 $ 0.00  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 0 0 (5,592)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 0.00 $ 0.00 $ 14.64  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (272,700) (400,987) (187,125)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 7.27 $ 6.93 $ 10.84  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 1 year 9 months 11 days 2 years 5 months 5 days 1 year  
Awards Other Than Options Aggregate Intrinsic Value $ 11,468 $ 4,409 $ 2,928  
Restricted Stock Units (RSUs)        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 900,025 1,607,917 1,081,804 835,841
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $ 7.82 $ 6.41 $ 6.77 $ 8.90
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 446,400 1,051,445 737,200  
Grant date fair value per share $ 9.81 $ 6.63 $ 5.52  
SharebasedcompensationArrangementbySharebasedPaymentAwardEquityInstrumentsOtherthanOptionsTRSUgrantsinPeriodWeightedAverageGrantDateFairvalue $ 6.53 $ 7.64 $ 11.75  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period (757,462) (483,239) (360,349)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value $ 10.59 $ 6.71 $ 5.52  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period (396,830) (42,093) (130,888)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value $ 6.83 $ 6.67 $ 7.66  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms 2 years 4 months 20 days 2 years 14 days 1 year 11 months 5 days  
Awards Other Than Options Aggregate Intrinsic Value $ 17,397 $ 11,168 $ 7,781  
Options and SARs        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Balance (shares), beginning of period 1,942,003 2,155,600 2,229,046  
Weighted average exercise price, beginning of period $ 9.17 $ 10.03 $ 12.52  
Granted (shares) 0 0 467,000  
Granted, Weighted Average Exercise Price $ 0.00 $ 0.00 $ 5.63  
Exercised (shares) (1,280,478) (22,500) (2,500)  
Exercised, Weighted Average Exercise Price $ 8.17 $ 6.23 $ 6.71  
Expired or forfeited (shares) (548,000) (191,097) (537,946)  
Expired or forfeited, Weighted Average Exercise Price $ 11.92 $ 19.20 $ 16.53  
Balance (shares) , end of period 113,525 1,942,003 2,155,600  
Weighted average exercise price, end of period $ 7.26 $ 9.17 $ 10.03  
Vested and expected to vest (shares) 113,140      
Vested and expected to vest, Weighted Average Exercise Price $ 7.26      
Options exercisable (shares) 89,525      
Options exercisable, Weighted Average Exercise Price $ 7.64      
Options outstanding, weighted average remaining contractual term 4 years 2 months 1 day 4 years 9 months 25 days 5 years 4 months 6 days  
Options vested and expected to vest, weighted average remaining contractual term 4 years 1 month 28 days      
Options exercisable, weighted average remaining contractual term 3 years 5 months 1 day      
Options outstanding, aggregate intrinsic value $ 1,371 $ 634 $ 904  
Options vested and expected to vest, aggregate intrinsic value 1,365      
Options exercisable, aggregate intrinsic value $ 1,046